pubmed semaglutide Once-weekly administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes Cosmetic Considerations of Semaglutide

Ozempic (GLP-1 Drugs) Ozempic Blindness Lawsuit A growing number of lawsuits have been filed against the makers of Ozempic and similar drugs due to severe adverse reactions, including vision loss

Intentionally formulated by a plastic surgeon to address the specific skin concerns that occur with GLP-1 usage, this multidimensional formula works in 4D to improve the appearance of facial skin DEFLATION

Two peer-reviewed studies published in Obesity Pillars demonstrate that patients receiving GLP-1 therapy within a comprehensive care protocol achieved higher average weight loss than reported in certain pharmaceutical trials, though cross-study comparisons are limited

47.2 meters in participants who were less than 75 years old